German biotech CureVac has more than tripled its market value to over $5 billion in an initial public offering launched on the US Nasdaq Global Market. Altogether 13.33...

Animal health biopharma Invetx has launched an antibody-based platform for the discovery and development of novel medicines for veterinarians and pet owners.

Bayer is to acquire UK biotech Kandy Therapeutics in a move that will expand its drug development pipeline in women’s healthcare.

Wacker Biotech, CDMO subsidiary of the Munich-based chemical group, is investing a mid-double-digit-million euro sum in its production facilities for biologics, LMPs...

The European Commission has signed a €63 million contract with Gilead Sciences to deliver batches of Veklury, Gilead’s name for the antiviral remdesivir, to the EU’s 27...

TechnipFMC has announced the first commercial application of its Hummingbird sustainable ethanol-to-ethylene technology, following a licensing deal with LanzaTech. The...

US biotechs Catalent and Humanigen are extending their standing collaboration on lenzilumab, Humanigen’s proprietary anti-human granulocyte macrophage-colony stimulating...

Roche has announced two separate collaborations, one for an investigational cancer treatment and the other for the discovery of small molecule drugs for treating immune...

The world’s governments are signing vaccine supply pacts fast and furiously now, as the world continues to hope an effective prevention against Covid-19 will be found...